does semaglutide effect blood pressure ADA 2026 Semaglutide and the reduction of

If your Current Weight is: Your new weight could be: Average study participant lost 15% *In the STEP 5 trial, participants for long-term treatment of adults with obesity, or overweight with at least one weight-related comorbidity, without diabetes, patients taking semaglutide (typically in doses of 2.4 mg once weekly) for weight management lost an average of about 15% of their body weight over 68 weeks

If nausea persists or becomes difficult to manage, contact your Genesis Lifestyle Medicine provider for support

In the SUSTAIN clinical trial program, the average HbA1c reductions ranged from 1.45% to 1.55%, depending on the dose (0.5 mg to 1 mg weekly)

Adjusting the dose, switching peptides, or stopping treatment are valid responses based on clinical judgment

The treatment began with 45 minutes of sun exposure on both front and back of the body, with a gradual increase in exposure over the following days